Amgen

Senior Associate Software Engineer

Amgen
Apply
21 hours ago
Hyderābād, IndiaSenior

Responsibilities

  • Configure, develop, test, deploy, and maintain IBM Maximo solutions and modules.
  • Develop Maximo Automation Scripts using Python/Jython and configure applications, databases, workflows, security, escalations, cron tasks, and scheduled jobs.
  • Develop and support Maximo Integration Framework integrations using Object Structures, Enterprise Services, Publish Channels, External Systems, Endpoints, Integration Controls, APIs, message queues, REST, JSON, XML, and file-based interfaces.
  • Provide technical and functional application support, including incident triage, root-cause analysis, defect resolution, production monitoring, release support, and on-call or after-hours support when required.
  • Participate in Agile delivery, requirements analysis, estimation, change control, release planning, deployment, production verification, and rollback planning.
  • Prepare and execute functional, integration, regression, smoke, negative, end-to-end, and User Acceptance Testing, while maintaining traceable test evidence and defect records.
  • Support GxP validation, data-integrity controls, audits, regulatory inspections, security reviews, access reviews, and technical-risk remediation.
  • Create and maintain solution designs, deployment instructions, validation documents, troubleshooting documentation, knowledge articles, operational procedures, and support runbooks.
  • Collaborate with product owners, business stakeholders, developers, QA, validation, infrastructure, integration, database, security, and external application teams.
  • Contribute to cross-skilling, process automation, operational improvements, and strategic technology initiatives.

Requirements

  • Bachelor’s degree in Computer Science, Information Technology, Software Engineering, Engineering, or a related field.
  • 8–9 years of relevant experience in application configuration, development, integration, testing, or production support.
  • Hands-on experience with IBM Maximo configuration, development, integration, or application support, including Application Designer, Database Configuration, Automation Scripts, workflows, escalations, cron tasks, security groups, and data restrictions.
  • Experience with Maximo Integration Framework components, REST APIs, web services, JSON, XML, file-based integrations, relational databases, and SQL.
  • Understanding of functional, integration, regression, smoke, negative, end-to-end, and User Acceptance Testing, including test-case creation, execution, evidence documentation, and defect management.
  • Understanding of GxP validation, change control, risk assessment, requirements traceability, test evidence, and controlled deployment.
  • Familiarity with Agile or Scrum delivery, Jira, Azure DevOps, Git, source control, peer reviews, and CI/CD processes.
  • Strong analytical, debugging, troubleshooting, documentation, communication, learning, and cross-skilling abilities.
  • Preferred experience includes IBM Maximo Application Suite or Maximo Manage, advanced SQL, Java, JavaScript, MuleSoft, SAP or ERP integrations, SAP EAM or SAP Plant Maintenance, data platforms, reporting tools, API-testing tools, and relevant technical or validation certifications.
  • Preferred exposure includes artificial intelligence, generative AI, machine learning, intelligent automation, Databricks, Azure Data Services, Snowflake, Power BI, Tableau, and BIRT.

Tech Stack

DatabricksGitJavaJavaScriptPostmanPythonSnowflakeSQL

Categories

Amgen

About Amgen

10,000+ employees

Amgen is a public biotechnology company that discovers, develops, manufactures, and sells biologic and biosimilar therapeutics for patients with serious diseases. Its portfolio and pipeline span oncology, cardiovascular disease, osteoporosis, inflammation, and rare diseases, marketed globally through direct sales and partnerships. Founded in 1980 and headquartered in Thousand Oaks, California (NASDAQ: AMGN), Amgen is a component of the Dow Jones Industrial Average and completed the acquisition of Horizon Therapeutics in 2023.

Contact me